Key facts
- It has raised $27.8M; the latest was Early Stage VC ($14.0M) in Nov 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, Tsinghua Innovation Ventures, Beijing Delian Yuntong Investment Management Company, Loyal Valley Capital, Comju Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for PULSECARE
- ·The full record, as it builds
Funding rounds
No funding rounds for PULSECARE are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PULSECARE
Manufacturer of medical devices intended for minimally invasive treatment. The company offers medical device products for indications such as cardiac electrophysiology (atrial fibrillation), liver tumours and intractable hypertension, thereby providing patients with better clinical outcomes and safety.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Employees
- 17
- Website
- pulsecare.cn/
- Ownership
- Privately Held (backing)
PULSECARE doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PULSECARE shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PULSECARE in its N-PORT filings yet. We sweep new filings monthly.